8-K 1 isco_8k-090908.htm INTERNATIONAL STEM CELL isco_8k-090908.htm

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): September 09, 2008
 
 
INTERNATIONAL STEM CELL CORPORATION
(Exact name of registrant as specified in its charter)
 
         
DELAWARE
  
0-51891
  
20-4494098
(State or other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)

     
2595 Jason Court
Oceanside, CA
  
92056
(Address of Principal Executive Offices)
  
(Zip Code)
 
Registrant’s telephone number, including area code: (760) 940-6383
 
 
 
(Former name or former address if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
 
Item 8.01 Other Events.
 
 
International Stem Cell Corporation (OTCBB: ISCO) announced today that it has entered into a manufacturing and supply agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network.
 
 
Item 9.01 Financial Statements and Exhibits.
 
 
 (d) Exhibits.
 
     
Exhibit
    
Number
  
Description
99.1
  
Press Release, September 09, 2008
 
 
 
 
 
2
 
 
 
 
SIGNATURES  
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  
 
  INTERNATIONAL STEM CELL CORPORATION  
       
Dated: September 09, 2008
By:
/s/ Jeffrey Janus  
    Name: Jeffrey Janus   
   
Title: President International Stem Cell Corporation
  
       
 
 
 
 
3
 
 
 
 
EXHIBIT INDEX
 
     
Exhibit
    
Number
  
Description
99.1
  
Press Release, dated September 09, 2008
 
 
 
 
4